Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008) [Phase 1]
This Phase 1 trial evaluated the effects of single doses of MK2637 and dextromethorphan on cerebral cortex excitability in schizophrenia. Th…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Smoking Cessation for Veterans With Severe and Persistent Mental Illness [Phase 2, Phase 3]
This is a Phase 2/3 clinical trial results update from the US Department of Veterans Affairs on smoking cessation for veterans with severe a…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients [NA]
Completed clinical trial evaluating whether acupuncture influences emotional measures and sleep quality in patients with schizophrenia or sc…
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia [Phase 4]
A Phase 4 clinical trial update evaluating the effectiveness of newer antipsychotics in comparison with conventional antipsychotics for schi…
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia [Phase 3]
Phase 3 study of paliperidone palmitate 3-month formulation for schizophrenia has completed. Results were posted on June 18, 2015.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder [Phase 1]
A Phase 1 randomized open-label pharmacokinetic study comparing LY03004 with Risperdal Consta in stable patients with schizophrenia or schiz…
-
FDA label_change · 2015-06-17FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone) filed by Viatris Specialty LLC, resulting in a labeling update.
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: CATIE- Schizophrenia Trial [Phase 4]
CATIE, a Phase 4 schizophrenia trial sponsored by the National Institute of Mental Health, has completed its study.
-
FDA approval · 2015-06-16FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc. The action relates t…
-
CLINICAL_TRIALS trial_result · 2015-06-15Clinical Trial Update: Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia [NA]
This entry reports the completion and posted results of a clinical trial evaluating cognitive adaptive training to improve medication adhere…
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia [Phase 1]
A Phase 1 clinical trial evaluating oxytocin for social cognitive and functional deficits in schizophrenia (also applicable to schizoaffecti…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients [Phase 4]
Phase 4 trial evaluating whether adding supported employment and skills training to ongoing pharmacotherapy improves outcomes in schizophren…
-
FDA approval · 2015-06-09FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2015-06-08Clinical Trial Update: Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia [Phase 4]
Clinical trial update of a Phase 4 study comparing aripiprazole once monthly to standard-of-care medication in outpatients with schizophreni…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia [Phase 1]
Phase 1 clinical trial evaluating N-acetylcysteine (NAC) for improving cognitive dysfunction in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia [Phase 2]
Phase 2 results evaluating the efficacy, safety, and tolerability of TC-5619 as augmentation therapy for negative symptoms and cognitive dys…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Cognitive Behavioral Social Skills Training for Improving Social Functioning in People With Schizophrenia [NA]
Clinical trial update on Cognitive Behavioral Social Skills Training (CBSST) for improving social functioning in people with schizophrenia; …
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia [Phase 1]
Phase 1 safety and tolerability study of an intramuscular depot formulation of aripiprazole in adults with schizophrenia. The trial has comp…
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Niacin Skin Flush Response in Patients With Schizophrenia [Phase 2, Phase 3]
Completion of a Phase 2/Phase 3 trial evaluating the niacin skin flush response in schizophrenia patients.
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307) [Phase 3]
Phase 3 trial of RO4917838 in schizophrenia has completed; the update notes the study status but does not provide results.
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Functional Rehabilitation for Older Patients With Schizophrenia [NA]
A US Department of Veterans Affairs trial evaluating functional rehabilitation for older adults with schizophrenia was terminated; results w…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia [EARLY_Phase 1]
A Phase 1 trial from the University of Copenhagen evaluating phosphodiesterase inhibitors for cognitive deficits in schizophrenia has been t…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689) [Phase 3]
This entry notes the completion of a long-term safety extension trial of asenapine in adults with schizophrenia who completed the prior prot…
-
CLINICAL_TRIALS research · 2015-05-27Clinical Trial Update: Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia [Phase 3]
This document provides an update on a Phase 3, risperidone-controlled multicenter clinical trial of iloperidone for schizophrenia.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Factors Association With Poor Physical Function in Older Adults With Schizophrenia
This completed clinical trial investigated factors associated with poor physical function in older adults with schizophrenia or schizoaffect…